Learn more about COVID-19 in Saskatchewan:

Google Translate Disclaimer

A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

COVID-19 Update Moderna Vaccine Arriving in Saskatchewan the Week of December 28

Released on December 23, 2020

With Health Canada’s approval of the Moderna vaccine for COVID-19, Saskatchewan is anticipating 4,900 doses to arrive in the province the week of December 28.

“The approval of the Moderna vaccine means more high-risk Saskatchewan residents will be able to be immunized against COVID-19,” Health Minister Paul Merriman said.  “This vaccine allows us to continue with our Phase 1 plans to target residents where they are living and working, whether in long term care and personal care homes, in northern and remote communities and in health care staff outside our major centres.”

The Moderna vaccine is approved for people 18 years and over.  It requires two doses, 28 days apart.  This vaccine requires refrigeration but at not the ultra-cold temperature required for the Pfizer COVID-19 vaccine.  This will allow public health to distribute this vaccine to more locations throughout the province, as the vaccine becomes available.

Phase 1 of Saskatchewan’s Vaccine Delivery Plan focuses on immunizing priority populations who are at a higher risk of exposure to the virus as well as those more at risk of serious illness.  Moderna vaccinations will target long term care and personal care home residents and staff; front-line health care workers most at risk for COVID-19 exposure; residents 80 years and older; and all residents 50 years and older living in northern and remote communities, as supply allows.

To December 22, 2020, 1,597 doses of the Pfizer COVID-19 vaccine have been provided to health care workers in Regina as part of the initial pilot and Saskatoon as part of Phase 1.

Widespread vaccine access to begin immunization of the general population will be part of Phase 2 of the delivery plan, tentatively beginning in April 2021.

As the COVID-19 vaccine is targeting the most at-risk populations as supply allows, it is necessary for all residents to continue to abide by public health orders to reduce transmission.  Wash your hands frequently; wear a mask in public places; maintain physical distancing; and stay home if you are experiencing even mild symptoms.

For information on Saskatchewan’s COVID-19 Vaccine Delivery Plan visit www.saskatchewan.ca/COVID19-vaccine.


For more information, contact:

Phone: 306-787-4083
Email: media@health.gov.sk.ca

We need your feedback to improve saskatchewan.ca. Help us improve